AzTrials
AzTrials

StressNCT05784831

Development and Feasibility Test of an Ecological Momentary Intervention (EMI) - ReApp, to Increase Reappraisal.

A study testing Reappraisal training and Ecological Momentary Assessment in people with Stress, run by University of Zurich at 1 site in Switzerland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of the current project is to develop and test Ecological Momentary Interventions (EMIs) to promote and improve stress resilience, specifically, an EMI to increase positive reappraisal. EMIs are mostly smartphone-based applications that deliver interventions to people as they go about in their daily lives. Read more about this study

Who is it for?
Ages 18 to 29 yearsHealthy volunteers can take part
Conditions the study is for
Stress
What is being tested?
Reappraisal training and Ecological Momentary Assessment
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
146 participants
Where
1 siteSwitzerland
Study dates
30 Apr 2021to 22 May 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 29 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • being a student
  • having sufficient knowledge of the German language
  • being a smartphone user
  • low results in a CERQ questionnaire (less than 13 points in the Positive Reappraisal subscale).

Who cannot join

  • having a current mental illness reported in the screening process.

Trial locations and contacts

1 site in 1 country.

Switzerland1 site
  • Psychiatric University Hospital Zurich

    Zurich, 8032

Other trials in Switzerland

About this study

Official title: Development and Feasibility Test of an Ecological Momentary Intervention (EMI) - ReApp, to Promote and Improve Stress Resilience, Specifically to Increase Reappraisal.

The aim of the current project is to develop and test Ecological Momentary Interventions (EMIs) to promote and improve stress resilience, specifically, an EMI to increase positive reappraisal.

EMIs are mostly smartphone-based applications that deliver interventions to people as they go about in their daily lives. The EMI tested here is based on theoretical and empirical findings and consists of several items and repeated training using various individual scenarios from participants' life that will be presented to participants via an app on their smartphones.

Read more

This study tests the efficacy of the EMI on a change in (i) reappraisal and (ii) indices of perceived stress. One hundred twenty healthy student participants, aged 18-29 will be invited to the study. Participants will be screened and those who score below 13 points of reappraisal skills in a Cognitive Emotion Regulation Questionnaire, will be included in the study. This is necessary in order to avoid a ceiling effect on reappraisal skills, which may be high in students.

Then, the participants will be randomly assigned to experimental (reappraisal EMI in regular and burst design) and control conditions (control EMA) and fill in questionnaires. The reappraisal EMI groups will be taught reappraisal skills and will be asked to apply them to personal situations repeatedly. The control EMA group will have the same app consisting of Ecological Momentary Assessment only. The training will last 21 consecutive days and the app will send (i) 5 prompts per day to ask about the current mood of the user in control and both experimental groups and (ii) at least two prompts per day resulting in a total of min. 42 reappraisal training sessions in the regular experimental group or 28 reappraisal training sessions in the burst experimental group. What is more, every participant has the possibility to trigger the EMA or EMI anytime they wish to. After using the app, participants will fill in some questionnaires again. The whole study will be conducted remotely (Video calls and app use) to avoid unnecessary COVID-related risks for participants.

Conditions
Stress
Being tested
Reappraisal training, Ecological Momentary Assessment
Keywords
stress, health, resilience

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Reappraisal trainingDevice

    Also called ReApp

    The EMI developed and tested here is based on theoretical and empirical findings and consists of several items and repeated training using various individual scenarios from participants' life that will be presented to participants via an app on their smartphones.

  • Ecological Momentary AssessmentDevice

    Also called EMA

    The EMA tested here collects data on participants' mood and behavior.

Study groups in NCT05784831
Study groupRoleWhat they receive
Regular Intervention GroupExperimentalGroup using the app delivering reappraisal training for 21 consecutive days.
Receives: Device: Reappraisal training
Burst Intervention GroupExperimentalGroup using the app delivering reappraisal training for 7 consecutive days, then having 7 days break and again using the app 7 consecutive days.
Receives: Device: Reappraisal training
Active Control GroupActive comparatorGroup using the ecological momentary assessment app for 21 consecutive days.
Receives: Device: Ecological Momentary Assessment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Perceived Stress Scale (PSS)

    Self-reported level of stress, scale range [0-40], higher score = worse outcome

    Measured: 21 days

  2. Beck Depression Inventory II (BDI-II)

    Self-reported depressive symptoms, scale range [0-63], higher score = worse outcome

    Measured: 21 days

  3. Cognitive Emotion Regulation Questionnaire (CERQ)

    Self-reported reappraisal skills, scale range [5-20], higher score = better outcome

    Measured: 21 days

  4. State-Trait Anxiety Inventory (STAI)

    Self-reported anxiety symptoms, scale range [20-80], higher score = worse outcome

    Measured: 21 days

  5. Emotion Regulation Questionnaire (ERQ)

    Self-reported reappraisal use, scale range [6-42], higher score = better outcome

    Measured: 21 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Mar 2023
  2. Study start30 Apr 2021
  3. Primary completion22 May 2022
  4. Study completion22 May 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
146 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05784831
Sponsor's protocol ID
UZH_ReApp
Status last verified
Mar 2023
First submitted
25 May 2022
Last updated
27 Mar 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: OSF

Publications

  • Marciniak MA, Yuen KSL, Kalisch R, Kleim B. Contextual factors influence effectiveness of cognitive reappraisal. Behav Res Ther. 2026 Jul;202:105046. doi: 10.1016/j.brat.2026.105046. Epub 2026 Apr 20.

    PubMed 42066391

Questions about this trial

What is this clinical trial studying?

A study testing Reappraisal training and Ecological Momentary Assessment in people with Stress, run by University of Zurich at 1 site in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 27 Mar 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Perceived Stress Scale (PSS) (time frame: 21 days). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05784831, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Mar 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in